# Debate Transcript

## Advocate — round 1

# Case for Acceptance

Every one of the five specialist reports converges on the same verdict: sound, useful, honestly reported work, scored 4–5 across the board, with the ethics reviewer giving a flat 5. That convergence matters not as five independent confirmations but as agreement on where the bar sits — and the manuscript clears it.

**The central claim is well-supported.** The headline result — 35–53% frame-binary reduction with preserved identification and quantification — rests on a genuinely informative benchmark design: a defined three-species mixture with known expected ratios (Table S3), replicated six times per condition, tested across two gradients and two acquisition modes, validated by two independent, widely-used pipelines (Sage/IonQuant and DIA-NN). The scientific validity reviewer confirms the ddaPASEF result is airtight by construction ("PSM/peptide/protein counts are identical... as expected, since MS/MS is untouched"), and the data-analysis reviewer independently credits the feature-level check in Figure 5 as going "beyond summary ratios" to validate quantitative fidelity directly.

**The authors' candor is itself evidence of rigor, not a weakness to be extracted.** Every reviewer highlights the same passages as strengths: the explicit statement that the benchmark is "controlled and narrow" (Section 3.7), the flagged confound between on-instrument denoising settings, and the acknowledgment that the 15-minute ddaPASEF parameter selection "is not fully out-of-sample." This is exactly the self-aware scoping the venue asks for — the ethics reviewer calls the disclosure "compliant" outright, and the reproducibility reviewer calls it "rare and valuable."

**It can be checked and built on.** Archived software (Zenodo DOI), public raw data (PXD070049), full parameter tables, and a verified point-for-point native round-trip mean the central engineering claim is independently testable today — not merely asserted.

**What reviewers flag are revision items, not disqualifying flaws**: releasing Table S2's full sweep, reporting quantified-protein overlap, and tightening abstract scope language are all concrete, addressable requests — none contradicts the reported evidence.

## Skeptic — round 1

## Opening argument against acceptance

**Lead objection (FIXABLE, but load-bearing):** The paper's title and central selling point is a "native-compatible .d directory" — yet "native-compatible" is validated only by (a) a self-referential round-trip identity check through dnoise's own reader, and (b) successful parsing by exactly two third-party tools, Sage and DIA-NN. The Introduction itself cites a half-dozen other native-.d readers and pipelines (MaxQuant, AlphaTims, OpenTIMS, i2MassChroQ, rustims) that a reader would reasonably expect a "native-compatible" file to work with, including Bruker's own vendor software. None of these are tested. The scientific_validity reviewer flags this only as a sweep item; no report treats it as central despite it underwriting the paper's entire premise that dnoise output is a drop-in replacement. This is fixable by testing against at least one additional independent reader, but as submitted the compatibility claim is narrower than the title implies.

**Second, compounding objection (FIXABLE):** The headline comparative numbers (53% ddaPASEF vs. 40% diaPASEF reduction, Figure 2) are confounded by an acquisition-mode-specific instrument setting — on-instrument denoising was enabled only for ddaPASEF (Section 3.1, acknowledged in Section 3.7) — yet the Abstract presents both figures side-by-side as parallel achievements of the tool.

**Third (FIXABLE but unresolved):** diaPASEF MS1-area ratios move *toward* expected values after removing supposedly uninformative points (Table S12), which is inconsistent with the paper's own framing that removed points carry no analytical signal (data_analysis and contribution_context reviewers both flag this; neither the authors nor the panel resolve the mechanism).

None of these is fatal individually, but together they mean the two headline claims — "native-compatible" and "35–53% reduction across modes" — are each less general than stated.

## Advocate — round 2

## Rebuttal

The skeptic's strongest point is the native-compatibility scope, and I'll concede it partially: the manuscript's own claim is that dnoise writes a "native-compatible .d directory," verified via byte-identical round-trip decoding (timsrust) plus successful analysis by exactly the two pipelines the benchmark uses (Sage, DIA-NN). It does not claim, and the abstract does not assert, that every tool in the Introduction's list of native readers has been tested. That is a real gap worth closing in revision — testing against one more independent reader (AlphaTims or MaxQuant) would strengthen the claim considerably — but it is a scope-narrowing request, not evidence the existing tests are wrong or that the format is broken. The reviewers who flagged it (scientific_validity, as a "sweep" item) treated it the same way.

On the second point, the skeptic's framing that the confound is "acknowledged... yet the Abstract presents both figures side-by-side as parallel achievements" overstates the case. Section 3.1 states outright: "**This difference should not be interpreted as an inherent advantage of one acquisition mode.**" That is the authors preempting exactly this criticism in the body text, not burying it. The abstract reporting a range (35–53%) is accurate reporting of measured values, not a claim of mechanistic parity.

On the third point: an unresolved mechanism for why MS1-area ratios move toward expectation is a request for explanation, not evidence against the result. The direction is favorable, not contradictory — nothing here shows degraded accuracy. It's a good question for the authors to address, not a flaw undermining the finding.

## Skeptic — round 2

## Round 2

I concede the advocate's core point: convergence of specialist scores toward 4–5 is real, and none of the five reports finds a claim that collapses under its own evidence. I am not arguing for rejection. But "revision items, not disqualifying flaws" undersells how load-bearing some of these revisions are, and the advocate's framing of convergence-as-evidence needs a check: five reports converging on the same concerns (parameter-selection opacity, diaPASEF confound, MS1-area anomaly) is one finding echoed five times, not five independent confirmations — the instructions to this panel explicitly warn against counting repetition as corroboration.

Two points from advocate's list deserve more weight than "concrete, addressable requests" implies. First, the reproducibility reviewer calls the missing Table S2 sweep a "**HARD reproducibility issue**": the defaults (gap=2, length=5) were chosen on data that is *also* the 15-minute ddaPASEF benchmark arm, and the paper's own justification ("prioritize stricter local continuity... over maximizing coverage") is a post-hoc narrative, not a documented decision rule. Since these same defaults are then applied unmodified to every other reported condition, this isn't cosmetic — it's the seed from which every headline number grows. Second, no reviewer's report registered that "native-compatible" is asserted for a whole ecosystem (MaxQuant, AlphaTims, i2MassChroQ are all cited in the Introduction) but tested against only two tools plus dnoise's own reader — a genuine collective blind spot, since every report treats compatibility as settled.

Both remain FIXABLE, not FATAL — but "accept as submitted" understates the revision burden.